塞伦诺夫可以控制乳腺来源的不朽和癌细胞的增殖和细胞死亡
Roudy C Ekyalongo1, Brenna Flowers1, Tanu Sharma1
1Department of Cancer Biology, Loyola University Chicago, Maywood, IL 60153, USA.
Cancers
|July 29, 2023
概括
失去SELENOF,这是一种对正常乳腺细胞至关重要的蛋白质,会加速乳腺癌的生长和瘤的形成. 恢复SELENOF可以诱导细胞死亡,表明其作为乳腺癌治疗点的潜力.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
背景情况:
- 在侵袭性乳腺瘤中,SELENOF的表达减少.
- 减少SELENOF可能会促进乳腺瘤发生.
研究的目的:
- 调查SELENOF在乳腺细胞增殖和瘤发生中的作用.
- 阐明SELENOF影响细胞循环调节和细胞死亡的机制.
主要方法:
- 在MCF-10A乳腺上皮细胞中删除和过度表达SELENOF.
- 在附着和3D培养中对细胞增殖的分析.
- 对细胞循环调节者的评估p21和p27.
- 对亡和自的评估.
- 与METABRIC患者数据库的相关性.
主要成果:
- 除SELENOF增强了增殖和废除了亡和自,导致3D培养中的光填充.
- SELENOF调节影响了p21和p27水平,与患者数据一致.
- 过度表达SELENOF诱导了亡和自.
结论:
- 在乳腺癌中,SELENOF作为瘤抑制剂起作用.
- 丢失的SELENOF通过促进增殖和抑制细胞死亡,有助于乳腺癌的发展.
- 塞伦诺夫通过p21和p27.0调节乳腺癌细胞命运.
更多相关视频
07:48Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures
Published on: December 26, 2016
11.4K
06:00Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
11.1K
相关概念视频
Replicative Cell Senescence
3.7K
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
3.7K
Mitogens and the Cell Cycle
6.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Cancer Stem Cells and Tumor Maintenance
5.0K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.0K
Cancer
48.7K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
48.7K
Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
